PI
LXRX icon

Putnam Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Putnam Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-41,487
Closed -$595K – 1213
2017
Q1 		$595K Sell
41,487
-5,920
-12% -$87.8K ﹤0.01% 1086
2016
Q4 		$656K Buy
+47,407
New +$761K ﹤0.01% 1085
2014
Q2 		– Sell
-37,175
Closed -$450K – 1493
2014
Q1 		$450K Sell
37,175
-1,903
-5% -$24.3K ﹤0.01% 1368
2013
Q4 		$493K Sell
39,078
-582
-1% -$9.26K ﹤0.01% 1351
2013
Q3 		$658K Sell
39,660
-3,483
-8% -$58.4K ﹤0.01% 1286
2013
Q2 		$655K Buy
+43,143
New +$656K ﹤0.01% 1280

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return